JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
Dimensional US Marketwide Value ETF
DFUV
$15.3B
| $7.06M | ﹤0.01% |
189,790
+87,986
| +86% | +$3.03M |
2022 Q4
4 quarters
|
|
2702
WisdomTree International Quality Dividend Growth Fund
IQDG
$686M
| $7.04M | ﹤0.01% |
194,107
-4,037
| -2% | -$134K |
2022 Q3
5 quarters
|
|
2703
Minerals Technologies
MTX
$2.07B
| $7.03M | ﹤0.01% |
98,603
-87,377
| -47% | -$5.18M |
2013 Q2
42 quarters
|
|
2704
PUT
Inspire Medical Systems
INSP
$2.02B
| $7.02M | ﹤0.01% |
+34,500
| New | +$5.59M |
2023 Q4
0 quarters
|
|
2705
PUT
Marathon Petroleum
MPC
$119B
| $7.02M | ﹤0.01% |
47,300
+9,400
| +25% | +$1.4M |
2021 Q3
9 quarters
|
|
2706
Viavi Solutions
VIAV
$11.6B
| $7.01M | ﹤0.01% |
696,016
-75,853
| -10% | -$637K |
2013 Q2
42 quarters
|
|
|
TGH
2707
DELISTED
Textainer Group Holdings limited
TGH
| $7.01M | ﹤0.01% |
142,435
+57,872
| +68% | +$2.66M |
2016 Q4
28 quarters
|
|
|
ECHO
2708
EchoStar
ECHO
$27.4B
| $7M | ﹤0.01% |
422,275
-147,241
| -26% | -$1.9M |
2018 Q4
20 quarters
|
|
2709
PUT
Blackrock
BLK
$164B
| $6.98M | ﹤0.01% |
8,600
+7,700
| +856% | +$5.38M |
2023 Q3
1 quarter
|
|
|
LTC
2710
LTC Properties
LTC
$2.32B
| $6.98M | ﹤0.01% |
217,199
+10,298
| +5% | +$333K |
2013 Q2
42 quarters
|
|
2711
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.89B
| $6.96M | ﹤0.01% |
69,785
+47,065
| +207% | +$4.7M |
2023 Q2
2 quarters
|
|
2712
Collegium Pharmaceutical
COLL
$717M
| $6.95M | ﹤0.01% |
225,748
+81,851
| +57% | +$2.05M |
2017 Q3
25 quarters
|
|
2713
GameStop
GME
$12.5B
| $6.95M | ﹤0.01% |
396,233
-12,291
| -3% | -$180K |
2013 Q2
42 quarters
|
|
2714
Usana Health Sciences
USNA
$274M
| $6.93M | ﹤0.01% |
129,240
+5,369
| +4% | +$272K |
2013 Q2
42 quarters
|
|
2715
Sanmina
SANM
$12.3B
| $6.92M | ﹤0.01% |
134,793
+7,527
| +6% | +$384K |
2013 Q2
42 quarters
|
|
2716
CALL
McDonald's
MCD
$164B
| $6.91M | ﹤0.01% |
23,300
-7,500
| -24% | -$2.04M |
2020 Q2
14 quarters
|
|
2717
Immunocore
IMCR
$1.53B
| $6.91M | ﹤0.01% |
101,082
+36,300
| +56% | +$1.89M |
2022 Q2
6 quarters
|
|
|
LUCK
2718
Lucky Strike Entertainment
LUCK
$721M
| $6.9M | ﹤0.01% |
487,502
-466,091
| -49% | -$5.12M |
2021 Q3
9 quarters
|
|
2719
Forward Air
FWRD
$537M
| $6.9M | ﹤0.01% |
109,740
-51,858
| -32% | -$3.49M |
2013 Q2
42 quarters
|
|
2720
Navient
NAVI
$862M
| $6.9M | ﹤0.01% |
370,399
-38,157
| -9% | -$666K |
2014 Q2
38 quarters
|
|
2721
JPMorgan US Value Factor ETF
JVAL
$995M
| $6.87M | ﹤0.01% |
178,080
+113,518
| +176% | +$4.04M |
2022 Q4
4 quarters
|
|
2722
QuinStreet
QNST
$857M
| $6.86M | ﹤0.01% |
535,102
+24,098
| +5% | +$271K |
2016 Q3
29 quarters
|
|
2723
Live Oak Bancshares
LOB
$1.7B
| $6.84M | ﹤0.01% |
150,435
+90,429
| +151% | +$3.04M |
2017 Q3
25 quarters
|
|
2724
Clarivate
CLVT
$947M
| $6.84M | ﹤0.01% |
738,233
+121,262
| +20% | +$896K |
2019 Q4
16 quarters
|
|
2725
Kura Oncology
KURA
$947M
| $6.8M | ﹤0.01% |
472,992
-8,877
| -2% | -$87.3K |
2017 Q3
25 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.